Table 3.
Acute Mortality (0-7 days) | Post-Acute Mortality (8-365 days) | Total Mortality (0-365 days) | |||||||
---|---|---|---|---|---|---|---|---|---|
|
|||||||||
Died (n=23) | Survived (n=157) | p value | Died (n=32) | Survived (n=125) | p value | Died (n=55) | Survived (n=125) | p value | |
Age, mean±STD | 45.3±17.2 | 36.4±15.6 | 0.010 | 49.8±16.1 | 32.9±13.6 | <0.001 | 47±16.6 | 32.9±13.6 | <0.001 |
GCS, median | 6 | 7 | 0.004 | 6 | 7 | 0.007 | 6 | 7 | <0.001 |
Male, # (%) | 15 (65.2) | 129 (82.2) | 0.073 | 26 (81.3) | 103 (82.4) | 0.880 | 41 (74.6) | 103 (82.4) | 0.232 |
CSF Weekly Average, ng/mL (n=133) | 0.25±0.17 | 0.19±0.12 | 0.214 | 0.26±0.17 | 0.18±0.10 | 0.013 | 0.25±0.17 | 0.18±0.10 | 0.012 |
Serum Weekly Average, ng/mL (n=124) | 130.75 ±17.26 | 159.47 ±60.57 | 0.054 | 147.04 ±44.46 | 155.23 ±51.84 | 0.353 | 140.06 ±58.30 | 155.23 ±51.84 | 0.107 |
STD=standard deviation; GCS=Glasgow Coma Scale; CSF=cerebrospinal fluid